论文部分内容阅读
我国首个获批的人源化单克隆抗体尼妥珠单抗注射液、具有自主知识产权的止血药物注射用尖吻蝮蛇血凝酶苏灵研发成功、国际首个无载体药物洗脱药物支架实现产业化……近年来,北京市的医药科技成果斐然,科技创新项目取得了丰硕成果,北京医药企业依靠科技创新谋发展,取得了一批重大科研成果,有效地带动了北京医药产业的核心竞争
China’s first approved humanized monoclonal antibody nimotuzumab injection, with independent intellectual property rights of hemostatic drugs injection Agkistrodon spirits Sulei successful research and development, the international first carrier-free drug-eluting drugs In recent years, the achievements in medical science and technology in Beijing have been impressive. Scientific and technological innovation projects have achieved fruitful results. Beijing pharmaceutical enterprises have relied on scientific and technological innovations for development and have achieved a number of major scientific research achievements, effectively driving the development of Beijing’s pharmaceutical industry Core competition